Connor, Clark & Lunn Investment Management (CC&L)’s Precigen PGEN Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-154,489	Closed	-$164K	–	1450
2023 Q1	$164K	Sell	154,489 -406,128	-72%	-$586K	﹤0.01%	1117
2022 Q4	$852K	Buy	560,617 +5,043	+0.9%	+$8.67K	﹤0.01%	747
2022 Q3	$1.18M	Buy	555,574 +428,535	+337%	+$904K	0.01%	617
2022 Q2	$170K	Buy	127,039 +96,454	+315%	+$143K	﹤0.01%	948
2022 Q1	$65K	Buy	+30,585	New	+$74.5K	﹤0.01%	997

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s PGEN Position: Q2 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Precigen (PGEN) in Q2 2023, closing a stake of 154,489 shares — an estimated $164K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in PGEN in Q1 2022 and held it in 5 quarters. The position peaked at $1.18M in Q3 2022. 138 funds tracked by Wall St. Rank hold PGEN as of Q2 2023.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Precigen position as of Q2 2023 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 154,489 Precigen shares in Q2 2023, an estimated $164K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Precigen in Q1 2022 and held it in 5 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Precigen position peaked at $1.18M in Q3 2022.
138 funds tracked by Wall St. Rank held Precigen as of Q2 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2023, filed 10 Aug 2023.